Annual Total Long Term Liabilities
$648.08 M
+$529.62 M+447.06%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual total long term liabilities is currently $648.08 million, with the most recent change of +$529.62 million (+447.06%) on 31 December 2023. During the last 3 years, it has risen by +$577.77 million (+821.73%). AMPH annual total long term liabilities is now at all-time high.AMPH Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$658.49 M
+$17.29 M+2.70%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly total long term liabilities is currently $658.49 million, with the most recent change of +$17.29 million (+2.70%) on 30 September 2024. Over the past year, it has dropped by -$33.04 million (-4.78%). AMPH quarterly long term liabilities is now -4.78% below its all-time high of $691.53 million, reached on 30 September 2023.AMPH Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +447.1% | -4.8% |
| 3 y3 years | +821.7% | +433.1% |
| 5 y5 years | +1429.6% | +907.1% |
AMPH Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +821.7% | -4.8% | +455.8% |
| 5 y | 5 years | at high | +1429.6% | -4.8% | +923.5% |
| alltime | all time | at high | +2872.7% | -4.8% | +3072.8% |
Amphastar Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $658.49 M(+2.7%) |
| June 2024 | - | $641.21 M(-0.9%) |
| Mar 2024 | - | $646.79 M(-0.2%) |
| Dec 2023 | $648.08 M(+447.1%) | $648.08 M(-6.3%) |
| Sept 2023 | - | $691.53 M(+28.6%) |
| June 2023 | - | $537.75 M(+350.2%) |
| Mar 2023 | - | $119.44 M(+0.8%) |
| Dec 2022 | $118.47 M(-3.1%) | $118.47 M(-0.7%) |
| Sept 2022 | - | $119.34 M(-1.2%) |
| June 2022 | - | $120.78 M(-1.3%) |
| Mar 2022 | - | $122.35 M(+0.1%) |
| Dec 2021 | $122.20 M(+73.8%) | $122.20 M(-1.1%) |
| Sept 2021 | - | $123.51 M(+67.0%) |
| June 2021 | - | $73.97 M(+9.3%) |
| Mar 2021 | - | $67.68 M(-3.7%) |
| Dec 2020 | $70.31 M(+1.3%) | $70.31 M(+6.5%) |
| Sept 2020 | - | $66.04 M(+2.6%) |
| June 2020 | - | $64.33 M(-2.7%) |
| Mar 2020 | - | $66.09 M(-4.8%) |
| Dec 2019 | $69.43 M | $69.43 M(+6.2%) |
| Sept 2019 | - | $65.39 M(-3.9%) |
| June 2019 | - | $68.01 M(+29.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $52.49 M(+23.9%) |
| Dec 2018 | $42.37 M(-15.5%) | $42.37 M(-0.9%) |
| Sept 2018 | - | $42.75 M(-1.8%) |
| June 2018 | - | $43.53 M(-13.2%) |
| Mar 2018 | - | $50.14 M(-0.0%) |
| Dec 2017 | $50.14 M(+32.4%) | $50.14 M(+0.9%) |
| Sept 2017 | - | $49.71 M(+5.8%) |
| June 2017 | - | $46.98 M(+26.3%) |
| Mar 2017 | - | $37.19 M(-1.8%) |
| Dec 2016 | $37.87 M(+9.2%) | $37.87 M(-4.3%) |
| Sept 2016 | - | $39.55 M(+11.5%) |
| June 2016 | - | $35.45 M(+5.8%) |
| Mar 2016 | - | $33.50 M(-3.4%) |
| Dec 2015 | $34.67 M(-22.8%) | $34.67 M(-14.6%) |
| Sept 2015 | - | $40.59 M(-8.3%) |
| June 2015 | - | $44.26 M(-1.9%) |
| Mar 2015 | - | $45.13 M(+0.5%) |
| Dec 2014 | $44.91 M(+106.0%) | $44.91 M(-18.2%) |
| Sept 2014 | - | $54.93 M(+3.2%) |
| June 2014 | - | $53.24 M(+156.6%) |
| Mar 2014 | - | $20.75 M(-4.8%) |
| Dec 2013 | $21.80 M(-9.0%) | $21.80 M |
| Dec 2012 | $23.96 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Amphastar Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Amphastar Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of AMPH is $648.08 M
What is the all time high annual total long term liabilities for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual total long term liabilities is $648.08 M
What is Amphastar Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, AMPH annual total long term liabilities has changed by +$529.62 M (+447.06%)
What is Amphastar Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AMPH is $658.49 M
What is the all time high quarterly long term liabilities for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly total long term liabilities is $691.53 M
What is Amphastar Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AMPH quarterly total long term liabilities has changed by -$33.04 M (-4.78%)